Stocktwits on MSN
NEONC receives FDA written feedback on NEO212 CMC development and capsule-to-tablet transition
FDA feedback provides detailed manufacturing and formulation requirements for continued late-stage development of NEO212CALABASAS, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings ...
Armata Pharmaceuticals is a Hold until Phase 3 AP-SA02 data, given a funding-dependent profile and limited margin for error.
Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a late clinical-stage biotechnology company ...
MarketBeat on MSN
Lineage Cell Therapeutics Maps COR1 Path With ‘Thaw and Inject' Cell Therapy Plan
Key Points Interested in Lineage Cell Therapeutics, Inc.? Here are five stocks we like better. Lineage Cell Therapeutics ...
The clinical blueprint for Merck & Co.’s prized TROP2-directed antibody-drug conjugate, sacituzumab tirumotecan (sac-TMT), ...
Randomized Phase 2 study in front-line setting progressing well, with nine sites actively recruiting and patient treatment ongoingData update expected in 2027, with trial completion in ...
KTVX Salt Lake City on MSN
Clinical psychologist suggests alternatives to a screen-filled summer for children
For parents feeling overwhelmed or uncertain about what activities to do with their kids who are home for the summer, ...
SHELTON, CT / ACCESS Newswire / July 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical ...
Akido’s model brings the visit to the patient. A community health worker stays at the patient’s side while AI prepares the ...
I qualified as a nurse with a First-Class Honours degree from the University of Birmingham in 2013. My final placement as a ...
READING, Pa. - Learn2Inject, an idea started by three Alvernia University mechanical engineering students, has become an ...
YourStory presents the daily news roundup from the Indian startup ecosystem and beyond. Here's the roundup for Wednesday, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results